These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 29492951)
21. Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis. Lu VM; Goyal A; Rovin RA; Lee A; McDonald KL J Neurooncol; 2019 Jan; 141(1):1-12. PubMed ID: 30392086 [TBL] [Abstract][Full Text] [Related]
22. Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis. Amaral T; Tampouri I; Eigentler T; Keim U; Klumpp B; Heinrich V; Zips D; Paulsen F; Gepfner-Tuma I; Skardelly M; Tatagiba M; Tabatabai G; Garbe C; Forschner A Immunotherapy; 2019 Mar; 11(4):297-309. PubMed ID: 30606066 [TBL] [Abstract][Full Text] [Related]
23. Treatment of Melanoma CNS Metastases. Jang S; Atkins MB Cancer Treat Res; 2016; 167():263-79. PubMed ID: 26601867 [TBL] [Abstract][Full Text] [Related]
24. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases? Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962 [TBL] [Abstract][Full Text] [Related]
25. Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data. Lehrer EJ; Peterson J; Brown PD; Sheehan JP; Quiñones-Hinojosa A; Zaorsky NG; Trifiletti DM Radiother Oncol; 2019 Jan; 130():104-112. PubMed ID: 30241791 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of patients with brain metastases from a melanoma]. Modesto A; Chira C; Sol JC; Lubrano V; Boulinguez S; Pagès C; Sibaud V; Gomez-Roca C; Moyal É; Meyer N Cancer Radiother; 2019 Apr; 23(2):147-150. PubMed ID: 30904418 [TBL] [Abstract][Full Text] [Related]
30. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery. Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540 [TBL] [Abstract][Full Text] [Related]
31. The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases. Moraes FY; Taunk NK; Marta GN; Suh JH; Yamada Y Oncologist; 2016 Feb; 21(2):244-51. PubMed ID: 26764249 [TBL] [Abstract][Full Text] [Related]
32. Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy. Tallet AV; Dhermain F; Le Rhun E; Noël G; Kirova YM Ann Oncol; 2017 Dec; 28(12):2962-2976. PubMed ID: 29045524 [TBL] [Abstract][Full Text] [Related]
33. Combination of anti-PD-1 therapy and stereotactic radiosurgery for a gastric cancer patient with brain metastasis: a case report. Ahn MJ; Lee K; Lee KH; Kim JW; Kim IY; Bae WK BMC Cancer; 2018 Feb; 18(1):173. PubMed ID: 29433469 [TBL] [Abstract][Full Text] [Related]
34. Stereotactic body radiation therapy and immunotherapy. Khalife M; Shahid K; Dabney RS; Phan AT Clin Adv Hematol Oncol; 2019 Sep; 17(9):518-523. PubMed ID: 31549973 [TBL] [Abstract][Full Text] [Related]
35. Frequent Use of Local Therapy Underscores Need for Multidisciplinary Care in the Management of Patients With Melanoma Brain Metastases Treated With PD-1 Inhibitors. Qian JM; Yu JB; Mahajan A; Goldberg SB; Kluger HM; Chiang VLS Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1113-1118. PubMed ID: 31479702 [TBL] [Abstract][Full Text] [Related]
36. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482 [TBL] [Abstract][Full Text] [Related]
37. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
38. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma. Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071 [TBL] [Abstract][Full Text] [Related]